Gallagher Rolls out Electric Fence Line

Aug 29, 2013

Gallagher Rolls out Electric Fence Line

By Amanda Brodhagen, Farms.com

Gallagher launched its newest line of fence chargers, i Series Fence Energizer Systems. The series was designed for its North American market.

“These Energizers deliver so much more information into the hands of the producer. It’s like having six people out on your farm constantly measuring the current and voltage of your fence and reporting the information back to you,” said Gallagher spokesperson Mark Harris.

Models are available in three sizes - 1200i, M1800i and M2800i. All three models are equipped with hand controllers which allow the producer to monitor fence performance. Additionally, the hand device can be used to turn it on and off and make adjustments to voltage strength. The hand device can be controlled up to 160 feet away.

Other features include monitoring through cell phone coverage. Producers can receive updates on problems relating to fencers via text message. Gallagher touts that its newest series will provide peace of mind to livestock producers.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.